Alicia Morgans

25PUBLICATIONS
201CO-AUTHORS
Predictive and prognostic markersAnimal behaviourCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Mar 26, 2026
Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy-Related Vasomotor Symptoms.

Daniel Sentana-Lledo, Alicia K Morgans

|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.

Emmanuel S Antonarakis, Qing Cao, Victoria Catharine

|Mar 19, 2026
Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study.

Neal D Shore, Daniel J George, Nasreen Khan

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 12, 2026
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer.

Alicia K Morgans, Christopher J D Wallis, Susan Halabi

Pageof 5

Frequent Collaborators

5 joint publications

Neal Shore

4 joint publications

Andrew J Armstrong

3 joint publications

Daniel J George

3 joint publications

Emmanuel S Antonarakis